Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Blood Coagulation and Fibrinolysis

• Publication date

  2001-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/00001721-200112000-00003PMID 11734662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• More porous fibrin gel structure obtained by interaction with Lys-plasminogen than with Glu-plasminogen

  2000cited by this paper
• Identification of the Mechanism Responsible for the Increased Fibrin Specificity of TNK-Tissue Plasminogen Activator Relative to Tissue Plasminogen Activator*

  2000cited by this paper
• Evaluation of the effects of levobupivacaine on clotting and fibrinolysis using thromboelastography.

  2000cited by this paper
• Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy.

  2000cited by this paper
• Thromboelastograph Assay for Measuring the Mechanical Strength of Fibrin Sealant Clots

  2000cited by this paper
• Thrombin-activable Fibrinolysis Inhibitor Attenuates (DD)E-mediated Stimulation of Plasminogen Activation by Reducing the Affinity of (DD)E for Tissue Plasminogen Activator

  2000cited by this paper
• Structural studies of fibrinolysis by electron microscopy.

  1998cited by this paper
• Resistance of gammaA/gamma' fibrin clots to fibrinolysis.

  1997cited by this paper
• Thrombin, Thrombomodulin and TAFI in the Molecular Link Between Coagulation and Fibrinolysis

  1997cited by this paper
• Resistance of γA/γ′ Fibrin Clots to Fibrinolysis*

  1997cited by this paper
• Effects of poloxamer 407 on the assembly, structure and dissolution of fibrin clots

  1996cited by this paper
• Rearrangements of the Fibrin Network and Spatial Distribution of Fibrinolytic Components during Plasma Clot Lysis

  1996cited by this paper
• Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains.

  1996cited by this paper
• Superficial accumulation of plasminogen during plasma clot lysis.

  1995cited by this paper
• Enzyme‐mediated proteolysis of fibrous biopolymers: Dissolution front movement in fibrin or collagen under conditions of diffusive or convective transport

  1995cited by this paper
• The Normal Thromboelastogram and Its Interpretation

  1995cited by this paper
• Effect of fibrin structure on plasmin-mediated dissolution of plasma clots.

  1995cited by this paper
• Thromboelastographic Study of Fibrinolytic Agents

  1995cited by this paper
• The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).

  1995cited by this paper
• The covalent structure of factor XIIIa crosslinked fibrinogen fibrils.

  1995cited by this paper
• Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis.

  1994cited by this paper
• Interactions of plasminogen with polymerizing fibrin and its derivatives, monitored with a photoaffinity cross-linker and electron microscopy.

  1994influential reference
• Overview on fibrinolysis: plasminogen activation pathways on fibrin and cell surfaces.

  1994cited by this paper
• Transport Phenomena and Clot Dissolving Therapy: An Experimental Investigation of Diffusion-Controlled and Permeation-Enhanced Fibrinolysis

  1994cited by this paper
• Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure.

  1993cited by this paper
• Molecular assembly of plasminogen and tissue-type plasminogen activator on an evolving fibrin surface.

  1993cited by this paper
• Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro.

  1992cited by this paper
• The effect of fibrin structure on fibrinolysis.

  1992cited by this paper
• Effects of N-terminal peptide of Glu-plasminogen on the activation of Glu-plasminogen and its conversion to Lys-plasminogen.

  1991cited by this paper
• Effect of Plasminogen and Tissue-type Plasminogen Activator on Fibrin Gel Structure

  1991influential reference
• The course and prerequisites of Lys-plasminogen formation during fibrinolysis.

  1988cited by this paper
• Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition.

  1988cited by this paper
• Release of N-terminal peptides from Glu-plasminogen by plasmin in the presence of fibrin.

  1986cited by this paper
• Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.

  1985cited by this paper
• Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.

  1984cited by this paper
• Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.

  1984cited by this paper
• The binding of human plasminogen to fibrin and fibrinogen.

  1983cited by this paper
• The binding of plasminogen to fibrin: evidence for plasminogen-bridging.

  1982cited by this paper
• Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

  1982cited by this paper
• Studies on the kinetics of plasminogen activation by tissue plasminogen activator.

  1982cited by this paper
• On the Regulation and Control of Fibrinolysis

  1980cited by this paper
• Plasminogen and plasmin.

  1976cited by this paper
• Resolution of experimental pulmonary emboli with heparin and streptokinase in different dosage regimens.

  1974cited by this paper
• The preparation and properties of human fibrinogen of relatively high solubility.

  1966cited by this paper
• Biochemical and chromatographic studies of certain activities associated with human fibrinogen preparations.

  1963cited by this paper
• SUBFRACTIONS OF HUMAN FIBRINOGEN; PREPARATION AND ANALYSIS.

  1963cited by this paper

• Hypoalbuminemia Increases Fibrin Clot Density and Impairs Fibrinolysis

  2025cites this paper
• 2.17 Fibrin

  2017cites this paper
• Novel sulfated xylogalactoarabinans from green seaweed Cladophora falklandica: Chemical structure and action on the fibrin network.

  2016cites this paper
• Investigating Interactions between Ultrasound Stimulated Microbubbles and the Fibrin Network of Blood Clots

  2016cites this paper
• Impact of homocysteine-thiolactone on plasma fibrin networks

  2014cites this paper
• Lysis Onset Time as Diagnostic Rotational Thromboelastometry Parameter for Fast Detection of Hyperfibrinolysis

  2014cites this paper
• Interactions between individual ultrasound-stimulated microbubbles and fibrin clots.

  2014cites this paper
• NOVEL BARRIERS TO THROMBOLYSIS: THE ROLE OF MECHANICAL STRESS AND NEUTROPHIL EXTRACELLULAR TRAPS

  2014cites this paper
• Interactions between ultrasound stimulated microbubbles and fibrin clots

  2013cites this paper
• possible mechanism of the increased thrombotic risk Elevated prothrombin results in clots with an altered fiber structure: a

  2013cites this paper
• studies structures in the regulation of fibrinolysis : kinetic and microscopic The interplay between tissue plasminogen activator domains and fibrin

  2011cites this paper
• 2.217 – Fibrin

  2011cites this paper
• The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies

  2010cites this paper
• Thrombelastometry‐guided thrombolytic therapy in massive pulmonary artery embolism

  2010cites this paper
• Deproteinization effects of NaOCl on acid-etched dentin in clinically-relevant vs prolonged periods of application. A confocal and environmental scanning electron microscopy study.

  2009cites this paper
• Fibrin formation and lysis studies in dengue virus infection

  2009cites this paper
• Immobilization of aprotinin to fibrinogen as a novel method for controlling degradation of fibrin gels.

  2007cites this paper
• Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation

  2006cites this paper
• Influence of homocysteine on fibrin network lysis

  2006cites this paper
• Insights into abnormal hemostasis in the Quebec platelet disorder from analyses of clot lysis

  2006cites this paper
• Structural Changes in the Fibrin Network of a Pretoria Family with Dysfibrinogenemia: A Scanning Electron Microscopical Study

  2006cites this paper
• In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.

  2006cites this paper
• Murine model of ferric chloride‐induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor

  2006cites this paper
• Confocal reflection imaging of 3D fibrin polymers.

  2006cites this paper
• Incorporation of fragment X into fibrin clots renders them more susceptible to lysis by plasmin.

  2006cites this paper
• Studies on the basis for the properties of fibrin produced from fibrinogen-containing γ′ chains

  2005cites this paper
• A new global assay of coagulation and fibrinolysis.

  2005cites this paper
• Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.

  2005cites this paper
• Studies on the basis for the properties of fibrin produced from fibrinogen-containing (cid:1)(cid:2) chains

  2005cites this paper
• A review of the therapeutic uses of thrombin

  2004cites this paper
• Investigation of residues in the fibrin(ogen) γ chain involved in tissue plasminogen activator binding and plasminogen activation

  2004cites this paper
• Peroxynitrite Inactivates Tissue Plasminogen Activator

  2004cites this paper
• A new euglobulin clot lysis assay for global fibrinolysis.

  2003cites this paper
• Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk.

  2003cites this paper
• Article Title: Elevated Prothrombin Results in Clots with an Altered Fiber Structure: a Possible Mechanism of the Increased Thrombotic Risk Running title: Elevated prothrombin alters clot structure

  2002cites this paper